Linklaters

In the course of a private placement in Europe and a public offering in the United States, Qiagen N.V., listed on the Frankfurt Stock Exchange (Prime Standard) and on NASDAQ, succeeded in placing a total of 31,625,000 new ordinary shares, including 4,125,000 ordinary shares from the green shoe option granted. The expected gross proceeds of the increase in capital amount to about EUR 437 million. The company plans to use the net proceeds from the offering to fund the acquisition of DxS Ltd. announced on 22 September 2009 as well as potential future acquisitions, to optimise its balance sheet structure and for general corporate purposes.

A Linklaters team led by Achim Kirchfeld advised Qiagen on this corporate action. The team also included, among others, Christoph Vaupel, Ulli Janssen, Dr. Thomas Dörmer, Dr. Ingo Scherer (all corporate/M&A), Dr. Sebastian Benz and Dr. Burkhard Wilhelm Bogumil (tax law).